Raymond J. Henley Iii

Array ( [id] => 369919 [patent_doc_number] => 07476692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Pharmaceutical compositions of safingol and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/782459 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9964 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476692.pdf [firstpage_image] =>[orig_patent_app_number] => 10782459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297318 [patent_doc_number] => 20040214806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma' [patent_app_type] => new [patent_app_number] => 10/487122 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3424 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214806.pdf [firstpage_image] =>[orig_patent_app_number] => 10487122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265158 [patent_doc_number] => 20040242694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Remedial agent for cardiac failure' [patent_app_type] => new [patent_app_number] => 10/487151 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4283 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242694.pdf [firstpage_image] =>[orig_patent_app_number] => 10487151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750122 [patent_doc_number] => 07022713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Hyperlipemia therapeutic agent' [patent_app_type] => utility [patent_app_number] => 10/780640 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1837 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022713.pdf [firstpage_image] =>[orig_patent_app_number] => 10780640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433587 [patent_doc_number] => 20040162349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events' [patent_app_type] => new [patent_app_number] => 10/778182 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3084 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162349.pdf [firstpage_image] =>[orig_patent_app_number] => 10778182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314896 [patent_doc_number] => 07524866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Prevention and treatment of androgen—deprivation induced osteoporosis' [patent_app_type] => utility [patent_app_number] => 10/778334 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15838 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 61 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524866.pdf [firstpage_image] =>[orig_patent_app_number] => 10778334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433565 [patent_doc_number] => 20040162346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Methods of cardioprotection using dichloroacetate in combination with an inotrope' [patent_app_type] => new [patent_app_number] => 10/778791 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9427 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162346.pdf [firstpage_image] =>[orig_patent_app_number] => 10778791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468173 [patent_doc_number] => 20040167095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Use of PDE V inhibitors for improved fecundity in mammals' [patent_app_type] => new [patent_app_number] => 10/778866 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7113 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167095.pdf [firstpage_image] =>[orig_patent_app_number] => 10778866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098605 [patent_doc_number] => 20050131064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Therapeutic use of aerosolized nitrosylating agent in cystic fibrosis' [patent_app_type] => utility [patent_app_number] => 10/772374 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2765 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131064.pdf [firstpage_image] =>[orig_patent_app_number] => 10772374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7156741 [patent_doc_number] => 20050027033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Polyurethanes for osteoimplants' [patent_app_type] => utility [patent_app_number] => 10/771736 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10022 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20050027033.pdf [firstpage_image] =>[orig_patent_app_number] => 10771736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707924 [patent_doc_number] => 07060709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Method of treating hepatic fibrosis' [patent_app_type] => utility [patent_app_number] => 10/767824 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4291 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060709.pdf [firstpage_image] =>[orig_patent_app_number] => 10767824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959552 [patent_doc_number] => 20050215565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents' [patent_app_type] => utility [patent_app_number] => 10/763539 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 145924 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215565.pdf [firstpage_image] =>[orig_patent_app_number] => 10763539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468348 [patent_doc_number] => 20040167114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Zinc ionophores as therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/759837 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16932 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167114.pdf [firstpage_image] =>[orig_patent_app_number] => 10759837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 785429 [patent_doc_number] => 06989400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-24 [patent_title] => 'Treatment of benign prostatic hyperplasia' [patent_app_type] => utility [patent_app_number] => 10/759337 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 14396 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989400.pdf [firstpage_image] =>[orig_patent_app_number] => 10759337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876900 [patent_doc_number] => 07358360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Risedronate sodium having a very low content of iron' [patent_app_type] => utility [patent_app_number] => 10/759919 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3081 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358360.pdf [firstpage_image] =>[orig_patent_app_number] => 10759919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411320 [patent_doc_number] => 20040176442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Potassium taurate bicarbonate and ascorbate' [patent_app_type] => new [patent_app_number] => 10/756205 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5866 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176442.pdf [firstpage_image] =>[orig_patent_app_number] => 10756205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468311 [patent_doc_number] => 20040167108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/753610 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11555 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167108.pdf [firstpage_image] =>[orig_patent_app_number] => 10753610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181388 [patent_doc_number] => 20040202682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Liquid-liquid interfacial nanoparticle assemblies' [patent_app_type] => new [patent_app_number] => 10/753868 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11617 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202682.pdf [firstpage_image] =>[orig_patent_app_number] => 10753868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672884 [patent_doc_number] => 20040180895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Use of a pyridazinone derivative' [patent_app_type] => new [patent_app_number] => 10/750846 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1759 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180895.pdf [firstpage_image] =>[orig_patent_app_number] => 10750846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163693 [patent_doc_number] => 20050085537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Method and composition for treating osteoporosis' [patent_app_type] => utility [patent_app_number] => 10/747671 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21953 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085537.pdf [firstpage_image] =>[orig_patent_app_number] => 10747671 [rel_patent_id] =>[rel_patent_doc_number] =>)